Full characterization of plasmids from Achromobacter ruhlandii isolates recovered from a single patient with cystic fibrosis (CF).


Journal

Revista Argentina de microbiologia
ISSN: 0325-7541
Titre abrégé: Rev Argent Microbiol
Pays: Argentina
ID NLM: 8002834

Informations de publication

Date de publication:
Historique:
received: 01 06 2020
revised: 24 11 2020
accepted: 24 01 2021
pubmed: 27 4 2021
medline: 7 4 2022
entrez: 26 4 2021
Statut: ppublish

Résumé

In the last decade Achromobacter spp. has been associated with chronic colonization in patients with cystic fibrosis (CF). Although Achromobacter xylosoxidans is the most frequent species recovered within this genus, other species such as A. ruhlandii have also been reported in these patients. Descriptions of mobile elements are scarce in Achromobacter and none of them have been originated in A. ruhlandii. The aim of this study was to report the full characterization of a plasmid which was maintained in four clonally related A. ruhlandii isolates. Between 2013 and 2015, nine A. ruhlandii isolates were recovered from a pediatric patient with CF at a hospital in Buenos Aires. Four selected clonally related isolates were sequenced by Illumina MiSeq, annotated using RAST and manually curated. The presence of a unique plasmid of 34096-bp and 50 CDS was observed in the four isolates, displaying only 1 nucleotide substitution translated into one amino acid change among them. These plasmids have a class 1 integron containing the aac-(6')-Ib gene, a mercury resistance operon region and the relE/stbE toxin/antitoxin system. Plasmids showed 79% similarity and 99% identity with pmatvim-7 from Pseudomonas aeruginosa. This is the first full description and characterization of a plasmid from A. ruhlandii which was maintained over time.

Identifiants

pubmed: 33896603
pii: S0325-7541(21)00048-1
doi: 10.1016/j.ram.2021.01.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-8

Informations de copyright

Copyright © 2021 Asociación Argentina de Microbiología. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Carla Steffanowski (C)

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, IbaViM, Argentina.

Mariana Papalia (M)

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, IbaViM, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.

Andrés Iriarte (A)

Laboratorio de Biología Computacional, Departamento de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Montevideo, Uruguay.

Mauricio Langleib (M)

Laboratorio de Biología Computacional, Departamento de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Montevideo, Uruguay.

Laura Galanternik (L)

Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.

Gabriel Gutkind (G)

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, IbaViM, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.

Vaughn Cooper (V)

University of Pittsburgh, Department of Microbiology and Molecular Genetics, Pittsburgh, United States.

María Soledad Ramírez (MS)

California State University, Fullerton, Department of Biological Science, Fullerton, United States.

Marcela Radice (M)

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, IbaViM, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: marcelaradice@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH